In addition to previous molecular studies, recent integrative analyses performed on larger cohorts have considerably improved our understanding of the molecular landscape of TFE3-tRCC and highlighted its heterogeneity [7,20]. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.